NEW YORK (
) hit a new 52-week high Wednesday as it is currently trading at $20.03, above its previous 52-week high of $20 with 93,458 shares traded as of 9:45 a.m. ET. Average volume has been 265,900 shares over the past 30 days.
Abiomed has a market cap of $711.2 million and is part of the
industry. Shares are up 97.3% year to date as of the close of trading on Tuesday.
Abiomed, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter
TheStreet Ratings rates Abiomed as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. You can view the full
52-week high stocks
or get investment ideas from our